Literature DB >> 31129726

Diagnosis and Management of Subcutaneous Soft Tissue Sarcoma.

Makoto Endo1, Nokitaka Setsu2, Toshifumi Fujiwara2, Takeaki Ishii2, Makoto Nakagawa2, Kenichiro Yahiro2, Atsushi Kimura2, Eijiro Shimada2, Yasuharu Nakashima2, Yoshihiro Matsumoto2.   

Abstract

OPINION STATEMENT: The proper diagnosis and treatment planning for subcutaneous soft tissue sarcoma is very important. Soft tissue tumors can occur anywhere in the body, but if they occur subcutaneously, patients can easily notice a subcutaneous soft tissue mass. Therefore, it is possible to determine through recording, the growth speed of the mass, which is often difficult to obtain with deep-situated soft tissue masses. Palpation can also provide information about the firmness and mobility of the mass. Thus, history taking and physical examinations are informative for subcutaneous soft tissue tumors, compared to tumors that occur deeply. Because subcutaneous soft tissue tumors are easily recognized, they are often resected, without sufficient imaging analyses or thorough treatment planning. An operation performed based on such an inadequate preoperative plan is called a "whoops surgery." In the case of "whoops surgeries," subsequent radical surgery is required to remove additional areas, including hematomas that result from the initial surgery, that require a wider range of resection and soft tissue reconstruction. Therefore, as with deep-seated soft tissue tumors, it is important to conduct careful imaging examinations and make appropriate preoperative plans for subcutaneous soft tissue tumors. Subcutaneous soft tissue sarcomas often show an invasive pattern, and such tumors require a more careful assessment to prevent local recurrence after surgery. During surgery, it is necessary to remove the entire infiltration area along the fascia. Sometimes, an adequately wide excision is necessary, which is considered the minimum necessary procedure to eradicate the lesion. As noted above, clinicians who see patients with subcutaneous soft tissue tumors are encouraged to have sufficient knowledge and experience regarding the diagnosis and treatment. This article is intended for all doctors who deal with subcutaneous soft tissue tumors and focuses on essential points regarding their diagnosis and management.

Entities:  

Keywords:  Sarcoma; Soft tissue sarcoma; Soft tissue tumor; Subcutaneous soft tissue sarcoma; Subcutaneous soft tissue tumor; Superficial soft tissue sarcoma

Year:  2019        PMID: 31129726     DOI: 10.1007/s11864-019-0656-z

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  73 in total

1.  THE CLASSIC: The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. The Journal of Bone and Joint Surgery, 1982;64:1121-1127.

Authors:  Henry J Mankin; Thomas A Lange; Suzanne S Spanier
Journal:  Clin Orthop Relat Res       Date:  2006-09       Impact factor: 4.176

2.  Soft-tissue sarcoma of the thigh: surgical margin influences local recurrence but not survival in 152 patients.

Authors:  S Vraa; J Keller; O S Nielsen; A G Jurik; O M Jensen
Journal:  Acta Orthop Scand       Date:  2001-02

3.  Surgical margin and its influence on survival in soft tissue sarcoma.

Authors:  Ian C Dickinson; Duncan J Whitwell; Diane Battistuta; Bridie Thompson; Nichola Strobel; Amit Duggal; Peter Steadman
Journal:  ANZ J Surg       Date:  2006-03       Impact factor: 1.872

4.  Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas.

Authors:  Alexander Stojadinovic; Denis H Y Leung; Axel Hoos; David P Jaques; Jonathan J Lewis; Murray F Brennan
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

5.  Prognostic factors in superficial adult soft tissue sarcomas: analysis of a series of 105 patients.

Authors:  L Cany; E Stoeckle; J M Coindre; G Kantor; F Bonichon; B N Bui
Journal:  J Surg Oncol       Date:  1999-05       Impact factor: 3.454

6.  Concordance of histopathologic and cytologic grading in musculoskeletal sarcomas: can grades obtained from analysis of the fine-needle aspirates serve as the basis for therapeutic decisions?

Authors:  Claudia Jones; Katharine Liu; Sharon Hirschowitz; Nancy Klipfel; Lester J Layfield
Journal:  Cancer       Date:  2002-04-25       Impact factor: 6.860

7.  Primary musculoskeletal neoplasms: effectiveness of core-needle biopsy.

Authors:  L Yao; S D Nelson; L L Seeger; J J Eckardt; F R Eilber
Journal:  Radiology       Date:  1999-09       Impact factor: 11.105

8.  Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremity.

Authors:  K M Alektiar; J Velasco; M J Zelefsky; J M Woodruff; J J Lewis; M F Brennan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-11-01       Impact factor: 7.038

9.  Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register.

Authors:  C S Trovik; H C Bauer; T A Alvegård; H Anderson; C Blomqvist; O Berlin; P Gustafson; G Saeter; A Wallöe
Journal:  Eur J Cancer       Date:  2000-04       Impact factor: 9.162

10.  Errors in diagnosis and margin determination of soft-tissue sarcomas initially treated at non-tertiary centers.

Authors:  R L Randall; J D Bruckner; M D Papenhausen; T Thurman; E U Conrad
Journal:  Orthopedics       Date:  2004-02       Impact factor: 1.390

View more
  4 in total

Review 1.  Applications of Chitosan and its Derivatives in Skin and Soft Tissue Diseases.

Authors:  Yidan Xia; Dongxu Wang; Da Liu; Jiayang Su; Ye Jin; Duo Wang; Beibei Han; Ziping Jiang; Bin Liu
Journal:  Front Bioeng Biotechnol       Date:  2022-05-02

2.  Nomogram Based on Ultrasonography and Clinical Features for Predicting Malignancy in Soft Tissue Tumors.

Authors:  Mengjie Wu; Yu Hu; Anjing Ren; Xiaojing Peng; Qian Ma; Cuilian Mao; Jing Hang; Ao Li
Journal:  Cancer Manag Res       Date:  2021-03-02       Impact factor: 3.989

3.  A demographic and clinical panorama of a sixteen-year cohort of soft tissue sarcoma patients in Brazil.

Authors:  Luiza Ohasi de Figueiredo; Augusto Afonso Guerra Júnior; Francisco de Assis Acurcio; Alessandra Maciel Almeida; Mariângela Leal Cherchiglia; Alberto Julius Alves Wainstein; Luiz Claudio Santos Thuler; Angélica Nogueira-Rodrigues
Journal:  Sci Rep       Date:  2021-11-18       Impact factor: 4.379

4.  Effectiveness and Tolerability of Anlotinib Plus PD-1 Inhibitors for Patients with Previously Treated Metastatic Soft-Tissue Sarcoma.

Authors:  Xin Sun; Jie Xu; Lu Xie; Wei Guo
Journal:  Int J Gen Med       Date:  2022-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.